ProCE Banner Activity

Complicated Clinical Infections: Independent Conference Coverage of ECCMID 2023

Video

In this on-demand webcast, expert faculty share insights on the most clinically relevant data on infections caused by gram-negative pathogens presented at ECCMID 2023, including treatment of MDR gram-negative infections such as KPC-producing CRE, CRAB, and MDR-P. aeruginosa; antimicrobial stewardship strategies for Enterobacterales bacteremia and VAP; and updates on investigational agents.

Released: May 03, 2023

Share

Faculty

David Van Duin

David Van Duin, MD, PhD, FIDSA, FAST

Professor of Medicine
Director, Immunocompromised Host Infectious Diseases Program
Division of Infectious Diseases
University of North Carolina
Chapel Hill, North Carolina

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an educational grant from Shionogi Inc.

Shionogi Inc

Disclosure

Primary Author

David Van Duin, MD, PhD, FIDSA, FAST

Professor of Medicine
Director, Immunocompromised Host Infectious Diseases Program
Division of Infectious Diseases
University of North Carolina
Chapel Hill, North Carolina

David van Duin, MD, PhD, FIDSA, FAST: consultant/advisor/speaker: Entasis, Merck, Pfizer, Qpex, Roche, Shionogi, Union, Utility; researcher: Merck, Shionogi.